Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

G03-52-01

GGTA1 KO Thymokidney

GIP/GLP-1a

GSK influenza virus H5N1 vaccine 1557484A

Galinpepimut-S + Montanide + GM-CSF

Gallium Ga 68 Gozetotide

Gluten- and casein-free diet

Glyoxalase 1 (Glo1) inducer

Granexin® gel (200 μM)

Green tea

Group A FMP2.1/AS01B

HB-adMSC

HTNV/PUUV DNA vaccine

Human Mesenchymal Stromal Cells

Hydrogen Peroxide

Hyperpolarized 129Xenon gas

IL-1Ra Kineret®

IV Remodulin

Ibrutinib

Ibrutinib 560 mg

Ibuprofen

Imatinib Mesylate

Impedance Threshold Device

Inhaled Treprostinil

Frequently asked questions